StockWatch
·

Jubilant Pharmova Ltd Q3 FY26 Results

JUBLPHARMAQ3 FY26 Results
Filing
MetricValue (₹ Cr)Q2 FY26Q3 FY25
Revenue2.1K7.9%16.5%
Total Income2.1K8.4%17.1%
Expenditure2.0K12.9%19.6%
PBT93.5050.9%28.5%
Net Profit55.8053.5%44.6%
OPM11.77%5.30pp13.16pp
NPM2.60%3.47pp2.92pp
EPS3.5253.6%44.7%
View full financials

Informational and educational content only. Not investment advice.